AI Healthcare company Presagen, in collaboration with US Fertility and Ovation Fertility (USA) and IVI-RMA (EU), presented a study showing that Life Whisperer’s new combined AI assessment of embryo quality can be used to help automate embryo classification, for the SART system used in the United States and in the ASEBIR system observed in Europe. This AI automated embryo classification can help improve standardization and reporting for IVF clinics, particularly large clinic networks.
The study was presented at the American Society for Reproductive Medicine (ASRM) 2023 in New Orleans by Dr Jonathan Hall from Presagen.
Life Whisperer uses Artificial Intelligence to non-invasively and instantly assess images of IVF patients’ embryos to evaluate their quality, in order to improve IVF outcomes. Life Whisperer uses two AI algorithms that assess embryo morphology. Life Whisperer Viability AI assesses embryo images to evaluate how likely they are to lead to a pregnancy, and Life Whisperer Genetics AI non-invasively assesses embryo images to evaluate how likely they are to be of high genetic integrity (euploid).
Presagen has recently combined both AIs into a single optimized AI embryo assessment. The combined AI has shown to improve AI performance in assessing overall embryo quality, including reduced time to pregnancy compared to either AI alone. Calculating the combined AI score from the two separate AI assessments is simple, and will make it easier for embryologists to rank and prioritize embryos for further testing or for transfer.
This study showed that different thresholds of the individual AI scores, and the combined AI score, can be used to automatically generate “Good”, “Fair” and “Poor” embryo morphology categories, which strongly correlate with embryo classification used in the United States (SART categories) and in Europe (ASEBIR categories). This allows the AI to support ongoing regulatory reporting requirements for clinics around the world, as well as supporting standardization and consistency of grading, improving lab efficiency, and assisting junior embryologists.
Life Whisperer is a world-leader in the application of AI in IVF. The Life Whisperer Viability and Genetics AI-based embryo assessment tools are the first to be commercialized in a series of applications that encompass the complete IVF journey. Life Whisperer aims to improve IVF success rates at every point and, as a result, reduce time-to-pregnancy, making IVF more affordable and accessible to patients globally. Life Whisperer is being used in IVF clinics around the world.
Presagen is an AI healthcare company that is changing the way clinics, patients, and medical data from around the world are connected through AI. Its platform, The Social Network for Healthcare, connects clinics and patients globally, and enables collaboration and data sharing to create scalable AI healthcare products that are affordable and accessible for all. The decentralized network democratizes the creation of AI products, promotes collaboration through incentives, and protects data privacy and ownership. With a focus on improving Women’s Health outcomes globally, Presagen’s first product, Life Whisperer, is being used by IVF clinics globally to improve pregnancy outcomes for couples struggling with fertility. With a vision of creating the largest network of clinics, patients, and medical data from around the world, Presagen is driving the future of AI Enhanced Healthcare.